Chinese Journal of Stroke ›› 2013, Vol. 8 ›› Issue (11): 899-903.

Previous Articles     Next Articles

Risk Factor Analysis and Progress on Treatment of Recurrent Cerebral Aneurysms after Endovascular Treatment

  

  1. Department of Neurosurgery, Changhai Hospital, Second Military Medical University, Shanghai 200433, China
  • Received:2013-08-20 Online:2013-11-20 Published:2013-11-20

颅内动脉瘤介入治疗后复发的危险因素分析及诊治进展

伍强军,杨鹏飞,黄清海,刘建民   

  1. 200433 上海
    第二军医大学附属长海医院临床神经医学中心、神经外科
  • 通讯作者: 刘建民 chstroke@163.com

Abstract:

Endovascular treatment has gradually become the most preferred treatment strategy for intracranial aneurysms. However, recurrence is the major concern about this modality. Recurrences of embolized intracranial aneurysms are related to their own characteristics, embolization materials and methods, immediate embolization results, patients' age and so on. Retreatment for recurrent aneurysms includes endovascular treatment and surgical clipping, which is usually selected based on the characteristics of the recurrent aneurysm and patients' demand. This review focuses on the risks of recurrence and progress on clinical treatment for this particular lesion.

Key words: Intracranial aneurysm; Recurrence; Endovasucular treatment; Surgical clipping

摘要:

血管内介入的方法现已广泛应用于颅内动脉瘤治疗,然而术后动脉瘤复发是目前该方法面临的主要问题。血管内介入治疗后的复发与颅内动脉瘤的自身特点、栓塞材料和方法、栓塞后即刻结果以及患者年龄等多种因素有关。复发类型不同,再治疗的方式也各异。再治疗策略主要包括再次介入栓塞和开颅夹闭,术式选择亦应根据复发动脉瘤的特点、患者需求等实际情况而定。本文主要针对颅内动脉瘤介入治疗后复发的危险因素及临床诊疗进展展开综述。

关键词: 颅内动脉瘤; 复发; 血管内介入治疗; 开颅夹闭